Erakusten 1 - 11 emaitzak -- 11 bilaketa honetara 'Alan L. Ho (15054328)', Bilaketaren denbora: 0,01s Findu emaitzak
  1. 1
    Figure S2 from Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy

    Figure S2 from Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy nork Laura Boucai (15054310)

    Argitaratua 2025
    Beste egile batzuk:
    Gogokoenen artean sartu
    Gorde:
  2. 2
    Table S1 from Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy

    Table S1 from Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy nork Laura Boucai (15054310)

    Argitaratua 2025
    Beste egile batzuk:
    Gogokoenen artean sartu
    Gorde:
  3. 3
    Table S6 from Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy

    Table S6 from Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy nork Laura Boucai (15054310)

    Argitaratua 2025
    Beste egile batzuk:
    Gogokoenen artean sartu
    Gorde:
  4. 4
    Table S2 from Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy

    Table S2 from Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy nork Laura Boucai (15054310)

    Argitaratua 2025
    Beste egile batzuk:
    Gogokoenen artean sartu
    Gorde:
  5. 5
    Figure S4 from Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy

    Figure S4 from Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy nork Laura Boucai (15054310)

    Argitaratua 2025
    Beste egile batzuk:
    Gogokoenen artean sartu
    Gorde:
  6. 6
    Figure S3 from Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy

    Figure S3 from Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy nork Laura Boucai (15054310)

    Argitaratua 2025
    Beste egile batzuk:
    Gogokoenen artean sartu
    Gorde:
  7. 7
    Table S4 from Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy

    Table S4 from Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy nork Laura Boucai (15054310)

    Argitaratua 2025
    Beste egile batzuk:
    Gogokoenen artean sartu
    Gorde:
  8. 8
    Figure S1 from Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy

    Figure S1 from Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy nork Laura Boucai (15054310)

    Argitaratua 2025
    Beste egile batzuk:
    Gogokoenen artean sartu
    Gorde:
  9. 9
    Table S3 from Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy

    Table S3 from Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy nork Laura Boucai (15054310)

    Argitaratua 2025
    Beste egile batzuk:
    Gogokoenen artean sartu
    Gorde:
  10. 10
    Table S5 from Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy

    Table S5 from Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy nork Laura Boucai (15054310)

    Argitaratua 2025
    Beste egile batzuk:
    Gogokoenen artean sartu
    Gorde:
  11. 11
    Supplementary Figure from Mutated HRAS Activates YAP1–AXL Signaling to Drive Metastasis of Head and Neck Cancer

    Supplementary Figure from Mutated HRAS Activates YAP1–AXL Signaling to Drive Metastasis of Head and Neck Cancer nork Sankar Jagadeeshan (15112900)

    Argitaratua 2025
    Beste egile batzuk:
    Gogokoenen artean sartu
    Gorde:

Bilaketa egiteko lanabesak: